PATISIRAN vs PAZOPANIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PATISIRAN vs PAZOPANIB: Safety Overview
| Metric | PATISIRAN | PAZOPANIB |
|---|---|---|
| Total FAERS Reports | 2,708 | 21,208 |
| Deaths Reported | 384 | 5,612 |
| Death Rate | 14.2% | 26.5% |
| Hospitalizations | 1,050 | 4,347 |
| Average Patient Age | 65.6 yrs | 61.2 yrs |
| % Female Patients | 34.2% | 41.2% |
| FDA Approval Date | Aug 10, 2018 | Apr 23, 2024 |
| Manufacturer | Alnylam Pharmaceuticals, Inc. | Golden State Medical Supply, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |